LATEST UPDATES ON DYSLIPIDEMIA
Early this year, the collaboration of the Philippine Heart Association, the Philippine Lipid and Atherosclerosis Society, and the Philippine Society of Endocrinology, Diabetes, and Metabolism provided us an update on the 2005’s local Clinical Practice Guidelines for the Management of Dyslipidemia. The update answered applicability issues of the different prevailing dyslipidemia guidelines from the different acclaimed international societies such as the ACC/ AHA, ESC etc.
Hope 3 Trial
highlights in the field of cardiology is the HOPE 3 trial. The results were based on a healthy population, with at least one CV risk factor, followed up for a median of 5.6 years. It used a 2×2 factorial design, daily rosuvastatin or placebo, plus daily candesartan/hydrochlorothiazide or placebo, to assess the safety and efficacy of cholesterol lowering, blood pressure (BP) lowering, or both.
Patient Centered Care
Is Patient-centered Care an Inevitable Consequence of the Social Media Revolution? This editorial shows us that the traditional physician and patient roles are changing and how we should respond.
Should we share the load? In this video, Dr Victor Montori from the Mayo Clinic introduces the concept of Shared Decision-Making with our Patients.